Overview and clarification of the current HR+ HER2- EBC treatment landscape – SPCC

SPCC shared on LinkedIn:

“With advancements in medical science, the landscape of breast cancer treatment is constantly evolving. How can we ensure the most effective approach for each patient?

Now available on-demand, our webinar offers a comprehensive overview of current treatment options. It features expert insights into the enhancement and personalisation of adjuvant endocrine therapy, as well as the de-escalation/escalation of surgery, radiotherapy, and adjuvant treatments.

Watch now.

Discussant: FIORITA POULAKAKI;
Experts: Michael Gnant, Stephen Johnston

This webinar is supported by an unrestricted educational grant from Eli Lilly.”